The global pandemic only re-emphasized the significance of healthcare and biotech firms. Some biotech companies that treat serious or life-threatening diseases are still red hot. After all, the average age of the world's population continues to rise, and diseases cannot be stopped -- at least, not yet. These factors make the healthcare industry a defensive sector -- no matter the state of the economy, there will always be a demand.

Let's take a look at three biotech stocks that are currently defying the bear market thanks to their innovative therapies.

Image source: Getty Images.

Continue reading

Source Fool.com